BRÈVE

sur Skin Tech Pharma Group

Skin Tech Pharma Group's RRS® HA Long Lasting Recognized at AMWC 2026

Skin Tech Pharma Group has received the Best Injectable in Skin Revitalization award at the AMWC Aesthetic Medicine Awards 2026 for its RRS® HA LONG LASTING product. Since its 2021 launch, this injectable has marked a significant advancement in the Skin Builder category, with over a million treatments worldwide. The award highlights its role in promoting regenerative aesthetic medicine and meeting the growing demand for natural outcomes in skin health.

RRS® HA Long Lasting is neither a skin booster nor a dermal filler, but a combination of both, featuring cross-linked hyaluronic acid and 15 amino acids. This results in immediate, natural-looking effects and ongoing improvements in skin quality. CEO Márcio Rodrigues views the award as a validation of the company's strategy focusing on scientific rigor and innovation. The product is designed to enhance skin aesthetics while maintaining high safety standards.

R. H.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Skin Tech Pharma Group